Published in Br J Pharmacol on November 01, 1990
Nomenclature and classification of purinoceptors. Pharmacol Rev (1994) 5.32
Differential effects of P2-purinoceptor antagonists on phospholipase C- and adenylyl cyclase-coupled P2Y-purinoceptors. Br J Pharmacol (1994) 1.77
Pharmacological and biochemical analysis of FPL 67156, a novel, selective inhibitor of ecto-ATPase. Br J Pharmacol (1995) 1.57
Characterization of the P1-purinoceptors mediating contraction of the rat colon muscularis mucosae. Br J Pharmacol (1992) 1.34
PPADS and suramin as antagonists at cloned P2Y- and P2U-purinoceptors. Br J Pharmacol (1996) 1.32
The regulation of aortic endothelial cells by purines and pyrimidines involves co-existing P2y-purinoceptors and nucleotide receptors linked to phospholipase C. Br J Pharmacol (1993) 1.25
PPADS: an antagonist at endothelial P2Y-purinoceptors but not P2U-purinoceptors. Br J Pharmacol (1995) 1.23
Effects of purines on the longitudinal muscle of the rat colon. Br J Pharmacol (1992) 1.17
Pharmacological analysis of ecto-ATPase inhibition: evidence for combined enzyme inhibition and receptor antagonism in P2X-purinoceptor ligands. Br J Pharmacol (1994) 1.10
Effects of the P2-purinoceptor antagonist, suramin, on human platelet aggregation induced by adenosine 5'-diphosphate. Br J Pharmacol (1992) 1.10
Separation of putative alpha 1A- and alpha 1B-adrenoceptor mediated components in the tension response of the rat vas deferens to electrical field stimulation. Br J Pharmacol (1992) 1.06
Differential effects of suramin on P2-purinoceptors mediating contraction of the guinea-pig vas deferens and urinary bladder. Br J Pharmacol (1994) 1.02
Characterization of purinoceptors mediating depolarization of rat isolated vagus nerve. Br J Pharmacol (1993) 1.01
Suramin inhibits excitatory junction potentials in guinea-pig isolated vas deferens. Br J Pharmacol (1992) 0.99
Prejunctional modulation of noradrenaline release in mouse and rat vas deferens: contribution of P1- and P2-purinoceptors. Br J Pharmacol (1993) 0.98
Evidence for the Recognition of Non-Nucleotide Antagonists Within the Transmembrane Domains of the Human P2Y(1) Receptor. Drug Dev Res (2002) 0.95
Evidence for a P2-purinoceptor mediating vasoconstriction by UTP, ATP and related nucleotides in the isolated pulmonary vascular bed of the rat. Br J Pharmacol (1996) 0.94
Purinoceptors mediating relaxation and spasm in the rat gastric fundus. Br J Pharmacol (1992) 0.94
Effects of suramin on contractions of the guinea-pig vas deferens induced by analogues of adenosine 5'-triphosphate. Br J Pharmacol (1995) 0.94
Stimulation of lumbar sympathetic nerves evokes contractions of cat colon circular muscle mediated by ATP and noradrenaline. Br J Pharmacol (1993) 0.94
Dual contractile effects of ATP released by field stimulation revealed by effects of alpha,beta-methylene ATP and suramin in rat tail artery. Br J Pharmacol (1993) 0.93
The nucleotide receptors on mouse C2C12 myotubes. Br J Pharmacol (1992) 0.92
Human P2Y2 receptor polymorphism: identification and pharmacological characterization of two allelic variants. Br J Pharmacol (1999) 0.91
Activation of the phospholipase C pathway by ATP is mediated exclusively through nucleotide type P2-purinoceptors in C2C12 myotubes. Br J Pharmacol (1993) 0.91
Suramin prevents duck hepatitis B virus infection in vivo. Antimicrob Agents Chemother (1993) 0.89
The activation of P1- and P2-purinoceptors in the guinea-pig left atrium by diadenosine polyphosphates. Br J Pharmacol (1996) 0.89
The role of P2Y(14) and other P2Y receptors in degranulation of human LAD2 mast cells. Purinergic Signal (2012) 0.86
4-Alkyloxyimino derivatives of uridine-5'-triphosphate: distal modification of potent agonists as a strategy for molecular probes of P2Y2, P2Y4, and P2Y6 receptors. J Med Chem (2014) 0.86
Physiological significance of P2X receptor-mediated vasoconstriction in five different types of arteries in rats. Purinergic Signal (2011) 0.86
Relative contribution of P2U- and P2Y-purinoceptors to endothelium-dependent vasodilatation in the golden hamster isolated mesenteric arterial bed. Br J Pharmacol (1996) 0.86
ATP and nitric oxide: inhibitory NANC neurotransmitters in the longitudinal muscle-myenteric plexus preparation of the rat ileum. Br J Pharmacol (1996) 0.86
Alpha1-adrenoceptor subtypes involved in vasoconstrictor responses to exogenous and neurally released noradrenaline in rat femoral resistance arteries. Br J Pharmacol (2004) 0.86
Suramin--a powerful inhibitor of neural ecto-diadenosine polyphosphate hydrolase. Br J Pharmacol (1996) 0.83
Role of ganglionic cotransmission in sympathetic control of the isolated bullfrog aorta. J Physiol (1997) 0.82
Ventilatory and carotid body chemoreceptor responses to purinergic P2X receptor antagonists in newborn rats. J Appl Physiol (1985) (2010) 0.80
Contractions mediated by alpha 1-adrenoceptors and P2-purinoceptors in a cat colon circular muscle. Br J Pharmacol (1994) 0.80
Evidence for the presence of both pre- and postjunctional P2-purinoceptor subtypes in human isolated urinary bladder. Br J Pharmacol (1995) 0.80
Inhibition of rat colon contractility by prostacyclin (IP-) receptor agonists: involvement of NANC neurotransmission. Br J Pharmacol (1995) 0.80
Reversal by suramin of neuromuscular block produced by pancuronium in the anaesthetized rat. Br J Pharmacol (1993) 0.79
Evidence for two distinct P2-purinoceptors subserving contraction of the rat anococcygeus smooth muscle. Br J Pharmacol (1996) 0.78
Vasoconstrictor responses to the P2x-purinoceptor agonist beta, gamma-methylene-L-ATP in human cutaneous and renal blood vessels. Br J Pharmacol (1995) 0.78
P2-purinoceptors mediating spasm of the isolated uterus of the non-pregnant guinea-pig. Br J Pharmacol (1996) 0.78
Blockade of P2X-purinoceptors by trypan blue in rat vas deferens. Br J Pharmacol (1994) 0.76
Diadenosine polyphosphate hydrolase from presynaptic plasma membranes of Torpedo electric organ. Biochem J (1997) 0.76
Responses of the longitudinal muscle and the muscularis mucosae of the rat duodenum to adenine and uracil nucleotides. Br J Pharmacol (1996) 0.75
DOCLASP - Docking ligands to target proteins using spatial and electrostatic congruence extracted from a known holoenzyme and applying simple geometrical transformations. F1000Res (2014) 0.75
Differential modulation of voltage-activated conductances by intracellular and extracellular cyclic nucleotides in leech salivary glands. Br J Pharmacol (1995) 0.75
Some quantitative uses of drug antagonists. Br J Pharmacol Chemother (1959) 41.90
Suramin: a reversible P2-purinoceptor antagonist in the mouse vas deferens. Br J Pharmacol (1988) 4.52
Suramin antagonizes responses to P2-purinoceptor agonists and purinergic nerve stimulation in the guinea-pig urinary bladder and taenia coli. Br J Pharmacol (1990) 3.34
The effects of some possible inhibitors of ectonucleotidases on the breakdown and pharmacological effects of ATP in the guinea-pig urinary bladder. Gen Pharmacol (1989) 1.98
Characterization of P2x-receptors in rabbit isolated ear artery. Br J Pharmacol (1990) 1.76
ATP, alpha,beta-methylene ATP and suramin as tools for characterization of vascular P2x receptors in the pithed rat. J Auton Pharmacol (1989) 1.28
Effects of equilibration time on the attainment of equilibrium between antagonists and drug receptors. Eur J Pharmacol (1980) 1.20
Effect of N-linked glycosylation on glycopeptide and glycoprotein structure. Curr Opin Chem Biol (1999) 2.11
Characterization of P2x-receptors in rabbit isolated ear artery. Br J Pharmacol (1990) 1.76
Dopexamine: a novel agonist at peripheral dopamine receptors and beta 2-adrenoceptors. Br J Pharmacol (1985) 1.61
The anti-obesity effect of rimonabant is associated with an improved serum lipid profile. Diabetes Obes Metab (2005) 1.37
Metabolic cooperation between vascular endothelial cells and smooth muscle cells in co-culture: changes in low density lipoprotein metabolism. J Cell Biol (1985) 1.27
The effects of dopexamine on the cardiovascular system of the dog. Br J Pharmacol (1985) 1.22
Probing the effect of the outer saccharide residues of N-linked glycans on peptide conformation. J Am Chem Soc (2001) 1.05
Coronary vasoconstriction in the conscious rabbit following intravenous infusion of L-NG-nitro-arginine. Br J Pharmacol (1991) 1.02
Aminoacyl-S-enzyme intermediates in beta-hydroxylations and alpha,beta-desaturations of amino acids in peptide antibiotics. Biochemistry (2001) 0.98
The pharmacology of sulpiride--a dopamine receptor antagonist. Gen Pharmacol (1982) 0.97
Quantitative analysis of the agonist and antagonist actions of some ATP analogues at P2X-purinoceptors in the rabbit ear artery. Br J Pharmacol (1993) 0.95
ADP-beta-F is not a selective P2y-receptor agonist in rabbit jugular vein. Br J Pharmacol (1989) 0.95
The cysteine proteinase inhibitor, E-64, reduces proteinuria in an experimental model of glomerulonephritis. Biochem Biophys Res Commun (1988) 0.91
Comparison of the cardiovascular actions of N,N-di-n-propyl dopamine and sodium nitroprusside in conscious and chloralose-anaesthetised dogs. J Cardiovasc Pharmacol (1982) 0.91
Presence of vasoconstrictor 5HT1-like receptors revealed by precontraction of rabbit isolated mesenteric artery. Br J Pharmacol (1995) 0.91
Antiplatelet and antithrombotic activity of SL65.0472, a mixed 5-HT1B/5-HT2A receptor antagonist. Thromb Haemost (2001) 0.91
5-Hydroxytryptamine1D-like receptors mediate contraction of partially depolarized rabbit renal arteries. J Pharmacol Exp Ther (1994) 0.89
An introduction to the pharmacologic properties of Dopacard (dopexamine hydrochloride). Am J Cardiol (1988) 0.88
Alfuzosin, a selective alpha 1-adrenoceptor antagonist in the lower urinary tract. Br J Pharmacol (1993) 0.88
Pre-contraction with histamine and U46619 unmasks a 5-HT1-like receptor in rabbit renal artery. Eur J Pharmacol (1993) 0.86
5-HT4 receptors, present in piglet atria and sensitive to SDZ 205-557, are absent in papillary muscle. Eur J Pharmacol (1992) 0.85
The effect of endothelial cell coculture on smooth muscle cell proliferation. J Vasc Surg (1993) 0.85
Interaction between glycophorin and phospholipids in recombined systems. J Supramol Struct (1979) 0.85
Glomerular basement membrane degradation by endogenous cysteine proteinases in isolated rat glomeruli. Kidney Int (1990) 0.84
A comparison of the anti-inflammatory activity of selective 5-lipoxygenase inhibitors with dexamethasone and colchicine in a model of zymosan induced inflammation in the rat knee joint and peritoneal cavity. Agents Actions (1991) 0.84
New insights into the pathological role of TNF-alpha in early cardiac dysfunction and subsequent heart failure after infarction in rats. Am J Physiol Heart Circ Physiol (2004) 0.84
XII. Fracture of the Tarsal Scaphoid: With a Report of Cases Treated by Operation. Ann Surg (1910) 0.82
Antithrombotic properties of SSR182289A, a new, orally active thrombin inhibitor. J Pharmacol Exp Ther (2003) 0.82
Evidence from electron paramagnetic resonance for function-related conformation changes in the anion-transport protein of human erythrocytes. Eur J Biochem (1981) 0.81
Pharmacological properties of FPL 63547, a novel inhibitor of angiotensin-converting enzyme. Br J Pharmacol (1990) 0.81
Cardiovascular profile of FPL 62129, a novel dihydropyridine calcium channel blocker, in anaesthetised dogs: a comparison with nifedipine. J Cardiovasc Pharmacol (1988) 0.81
Pharmacological modification of 12-0-tetradecanoylphorbol-13-acetate induced inflammation and epidermal cell proliferation in mouse skin. Agents Actions (1988) 0.80
Distance determinations at the active site of kidney (Na+ + K+)-ATPase by Mn(II) ion electron paramagnetic resonance. FEBS Lett (1980) 0.80
Preferential biliary elimination of FPL 63547, a novel inhibitor of angiotensin-converting enzyme, in the rat. Br J Pharmacol (1990) 0.79
Antithrombotic activity of a monoclonal antibody inducing the substrate form of plasminogen activator inhibitor type 1 in rat models of venous and arterial thrombosis. Br J Pharmacol (1998) 0.78
Role of distinct subpopulations of peritoneal macrophages in the regulation of reactive oxygen species release. Free Radic Biol Med (1999) 0.77
Pharmacological profile of SL 59.1227, a novel inhibitor of the sodium/hydrogen exchanger. Br J Pharmacol (2000) 0.77
Sumatriptan-induced saphenous venoconstriction in the anaesthetized dog through 5-HT1-like receptor activation. Br J Pharmacol (1995) 0.77
Effects of SL 65.0472, a novel 5-HT receptor antagonist, on 5-HT receptor mediated vascular contraction. Eur J Pharmacol (2000) 0.76
Antithrombotic actions of the thrombin inhibitor, argatroban, in a canine model of coronary cyclic flow: comparison with heparin. Br J Pharmacol (1996) 0.75
Comparison of the haemodynamic profiles of elgodipine and nicardipine in the anaesthetized dog. Br J Pharmacol (1994) 0.75
Diagnosis and classification of erotomania. Am J Psychiatry (1990) 0.75
Regulation of ATP-sensitive potassium channel mRNA expression in rat kidney following ischemic injury. Biochem Biophys Res Commun (2000) 0.75
Pre- and post-synaptic activities of some dopamine analogues and related compounds [proceedings]. Br J Pharmacol (1979) 0.75
Substrate-metal interactions at the active site of kidney (Na+ + K+)-ATPase characterized by Mn(II) electron paramagnetic resonance. Biochem Biophys Res Commun (1980) 0.75
Evaluating the implementation of team nursing in a clinical setting. Br J Nurs (1993) 0.75
Effective pulmonary flow, aortic flow and cardiac output: in vitro and in vivo comparisons in the dog. Exp Physiol (1990) 0.75
Density of low temperature ice. Science (1970) 0.75
The rabbit isolated arterially perfused intestinal segment preparation: a model for vascular dopamine receptors. J Pharmacol Methods (1983) 0.75
Coronary and systemic hemodynamic effects of the putative nitric oxide donor, FK 409, in comparison with nitroglycerin in conscious and anesthetized dogs. J Cardiovasc Pharmacol (1995) 0.75
Combination of aspirin and metoclopramide produces a synergistic antithrombotic effect in a canine model of coronary artery thrombosis. Fundam Clin Pharmacol (1997) 0.75
A reorganisation that improves patient care. An evaluation of team nursing in acute clinical settings. Prof Nurse (1994) 0.75
Adenosine 5'-(2-fluorodiphosphate) is not a selective P2Y purinoceptor agonist in the rabbit jugular vein. J Pharmacol Exp Ther (1992) 0.75
SSR182289A enhances thrombolysis induced by fibrinolytic agents in rabbit models of venous and arterial thrombosis. J Thromb Haemost (2004) 0.75
Hemi-ellipsoidal mirror infrared reflectometer: development and operation. Appl Opt (1976) 0.75
Effects of ciclosporin and protein synthesis inhibitors on cutaneous inflammation in mouse skin. Skin Pharmacol (1989) 0.75
Inhibition of collagen- and ADP-induced platelet aggregation by substance P in vivo: involvement of endothelium-derived relaxing factor. J Cardiovasc Pharmacol (1990) 0.75
The development of stroke units: the British experience. Rehabil Nurs (1995) 0.75
Anticoagulant activity and pharmacokinetic properties of a sub-cutaneously administered mixed micellar formulation of argatroban in experimental animals. Thromb Haemost (2000) 0.75
Influence of vascular tone on vasoconstrictor responses to the 5-HT 1-like receptor agonist sumatriptan in anaesthetised rabbits. Eur J Pharmacol (1996) 0.75
Network theory--a systematic method for literature review. Nurse Educ Today (1992) 0.75
Manganese electron paramagnetic resonance studies of sheep kidney (Na+ + K+)-ATPase. Interactions of substrates and activators at a single Mn2+ binding site. Biochemistry (1979) 0.75
Refractive Indices and Densities of H2O and CO(2) Films Condensed on Cryogenic Surfaces. Appl Opt (1971) 0.75
Stroke units: centres of nursing innovation. Br J Nurs (1996) 0.75